XML 52 R36.htm IDEA: XBRL DOCUMENT v3.7.0.1
SHAREHOLDERS' EQUITY (Tables)
12 Months Ended
Dec. 31, 2016
Share-based Compensation [Abstract]  
Summary Of Stock Options And RSUs Granted
The following is a summary of the Company's stock options and RSUs granted among the various plans:

   
Year ended
December 31, 2016
 
   
Number
of options
   
Weighted
average
exercise
price
   
Weighted average remaining contractual term
(in years)
   
Aggregate
intrinsic
value
 
                         
Outstanding at beginning of year
   
6,465,782
   
$
4.81
     
4.76
   
$
88
 
Granted
   
1,777,875
   
$
1.43
                 
Exercised
   
(72,832
)
 
$
1.18
                 
Forfeited or expired
   
(680,652
)
 
$
6.78
                 
                                 
Outstanding at end of the year
   
7,490,173
   
$
3.86
     
4.33
   
$
6,003
 
                                 
Options exercisable at end of the year
   
4,021,641
   
$
6.01
     
3.92
   
$
1,639
 
                                 
Vested and expected to vest
   
6,611,066
   
$
4.20
     
4.26
   
$
4,842
 

   
Year ended
December 31, 2016  
 
   
Number
of RSUs
   
Aggregate
intrinsic
value
 
             
Outstanding at beginning of year
   
106,768
   
$
120
 
Granted
   
-
         
Exercised
   
(59,233
)
       
Forfeited
   
-
         
                 
Outstanding at end of the year
   
47,535
   
$
125
 
                 
Vested and expected to vest
   
43,118
   
$
113
 
Summary Of Stock Options And RSUs Granted Separated Into Ranges Of Exercise Price
The following is a summary of the Company's stock options and RSUs granted separated into ranges of exercise price:

Exercise price
(range)
   
Options and RSUs outstanding
as of
December 31, 2016
   
Weighted
average
remaining
contractual
life (years)
   
Weighted
average
exercise
price
   
Options and RSUs exercisable
as of
December 31, 2016
   
Remaining contractual life (years for exercisable options
   
Weighted
average
exercise
price
 
$
               
$
               
$
 
                                       
RSUs 0.0
     
47,535
           
0.00
     
-
             
0.01-2.00
     
4,015,854
     
4.65
     
1.19
     
1,064,599
     
4.36
     
1.19
 
2.01-4.00
     
921,522
     
4.72
     
2.49
     
420,067
     
4.37
     
2.62
 
4.01-6.00
     
933,139
     
2.94
     
5.22
     
917,317
     
2.88
     
5.23
 
6.01-8.00
     
41,500
     
5.39
     
6.84
     
41,500
     
5.39
     
6.84
 
8.01-10.00
     
845,074
     
4.17
     
9.07
     
845,074
     
4.17
     
9.07
 
10.01-13.04
     
733,084
     
3.94
     
12.35
     
733,084
     
3.94
     
12.35
 
                                                   
       
7,537,708
                     
4,021,641
                 
Schedule Of Equity-Based Compensation Expense
The total equity-based compensation expense related to all of the Company's equity-based awards, recognized for the years ended December 31, 2014, 2015 and 2016, was comprised as follows:

   
Year ended
December 31,
 
   
2014
   
2015
   
2016
 
                   
Cost of revenues
 
$
215
   
$
73
   
$
30
 
Research and development
   
1,625
     
736
     
151
 
Selling and marketing
   
674
     
495
     
369
 
General and administrative
   
831
     
321
     
521
 
                         
Total stock-based compensation expenses
 
$
3,345
   
$
1,625
   
$
1,071